CLOV vs MRNA · rev $1.37B vs rev $1.94B
Clover Health Investments Corp (CLOV) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
CLOV currently screens at market cap $1.55B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the CLOV and MRNA stock pages for the full models.
Not investment advice.